AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians

AMN Healthcare Services, Inc. AMN recently launched the latest version of AMN Passport — the most powerful and practical mobile app — that will enable travel nurses and allied professionals to find, book and manage their assignments. The company’s new offering will help clinicians with the healthcare industry’s most all-inclusive and easiest-to-use application for their mobile devices.

The introduction of this newest version of AMN Passport is likely to provide further boost to the company’s broad service portfolio.

Benefits of AMN Passport

Notably, this application aids clinicians to primarily personalize job preferences, manage an update credentials and professional profiles, thereby improving healthcare professionals’ experience.

AMN Healthcare — a leader and innovator in healthcare total talent services — remains focused in offering the best possible experience to its clinicians and continues to enhance AMN Passport in order to maximize the professional and personal experience of their assignments.

Recent Development

In June 2020, AMN Healthcare introduced a personalized, technology-enabled and clinically based service for businesses and other organizations that will help them in protecting the health and safety of employees as they return to work. The company’s return-to-work solutions offer each employer all the required staffing and protocols, which comprise temperature checks, COVID-19 testing, onsite clinic support, quarantine management and a telehealth platform.

Market Prospects

Per a report by Allied Market Research, the global healthcare IT (HCIT) market estimates that the market for HCIT solutions and services was $125 billion in 2015 and is projected to reach $297 billion by 2022, witnessing a CAGR of 13.2%.

Growing demand for quality healthcare services and solutions together with patient safety & care, proactive supportive government initiatives, and increase in acceptance of mHealth & telehealth practices have been driving this market. Further, growing adoption of smartphones is bolstering healthcare IT market growth.

Hence, the introduction of this new version of the mobile app is a well-timed one.

Price Performance

Over the past year, shares of this Zacks Rank #2 (Buy) company have lost 5.7% against the industry’s rally of 19.3%.

Other Stocks to Consider

Some other top-ranked stocks from the broader medical space include West Pharmaceutical Services, Inc. WST, Thermo Fisher Scientific Inc. TMO and PerkinElmer, Inc. PKI. While PerkinElmer sports a Zacks Rank of 1 (Strong Buy), both West Pharmaceuticals and Thermo Fisher carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

PerkinElmer has a projected long-term earnings growth rate of 17.4%.

West Pharmaceutical has a projected long-term earnings growth rate of 17.4%.

Thermo Fisher has an estimated long-term earnings growth rate of 15%.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q2 2020, while the S&P 500 gained an impressive +44.0%, five of our strategies returned +50.9%, +93.8%, +122.2%, +153.0%, and even +156.8%.

This outperformance has not just been a recent phenomenon. From 2000 – Q2 2020, while the S&P averaged +5.5% per year, our top strategies averaged up to +51.7% per year.

See their latest picks free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PerkinElmer, Inc. (PKI): Free Stock Analysis Report
Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report
West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report
AMN Healthcare Services Inc (AMN): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More